NEW YORK (GenomeWeb News) – GE Healthcare and Geron jointly announced today that they will collaborate on developing and selling human embryonic stem cell-based assays for drug discovery, development, and toxicity screening.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.